Answers are grounded in this paper and cite their sources.
Retrospective cohort study demonstrates eosinophil levels predict no-reflow risk in STEMI patients with diabetes, highlighting opportunities to identify and mitigate high-risk outcomes.
DM patients, which provides guidance for clinicians to identify patients at a higher risk of developing no-reflow and lowering their risk.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: